Harrington Discovery Institute is leading the way, forging new paths and advancing drug development in a variety of disease areas, including cancer, heart, brain health and rare diseases.
Make a Gift Contact Us Download Brochure
Join us on the path to cures. Your support will make the ‘impossible’ possible.
1 in 3 adults
suffers from multiple chronic conditions, such as Alzheimer’s, cancer, or heart diseaseSource
500,000 new cases
of Alzheimer’s disease will be diagnosed this yearSource
worldwide suffer from a rare diseaseSource
from COVID-19 have been reported globally with the true death toll considered to be significantly higher4Source
Today, we face a major gap between promising scientific discoveries and new medicines due to a lack of financial resources and guidance for scientists. Interest from pharmaceutical companies and venture capitalists can only be attracted once discoveries have been shown to have strong potential for commercial success.
Harrington Discovery Institute fills this critical gap by providing philanthropic funding and drug development and business development expertise to advance promising discoveries out of academic labs and into the commercial realm where they can make it to patients.
Medicines in the making
Scholar projects funded and supported under Harrington programs
Academic medical centers where Harrington Scholars conduct their work
Start-ups created through partnerships with venture capital and accelerators
Medicines in the clinic
Drugs and treatments being evaluated in clinical trials for use in humans
Licenses to pharma
Partnerships with pharmaceutical companies advance and commercialize technologies
Your gift to Harrington Discovery Institute at University Hospitals supports the advancement of breakthrough discoveries into new medicines.Make a Gift Contact Us Call Us: 216-278-7133
For additional information about supporting Harrington Discovery Institute, please contact Tyrone Gorden, Vice President of Global Development, at 216-278-7133 or Tyrone.Gorden@HarringtonDiscovery.org.